Synonyms: CXA-101 | CXA101 | FR-264205 | FR264205 | Zerbaxa® (ceftolozane + tazobactam)
ceftolozane is an approved drug (FDA (2014), EMA (2015))
Compound class:
Synthetic organic
Comment: Ceftolozane is a semi-synthetic, broad-spectrum, fifth-generation cephalosporin antibacterial with activity against certain Gram-negative (e.g. Pseudomonas spp.) and Gram-positive bacteria [6].
|
|
No information available. |
Summary of Clinical Use ![]() |
Ceftolozane is approved by the FDA in 2014 for use in combination with the β-lactamase inhibitor tazobactam [1] for the treatment of serious infections, including intra-abdominal infections and complicated urinary tract infections, and hospital-acquired bacterial pneumonia (HAP) and ventilator-associated bacterial pneumonia (VAP) where Pseudomonas aeruginosa is often the causative baterium [2-5]. |